美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ZYPREXA"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ZYPREXA 020592 001 NDA OLANZAPINE TABLET;ORAL 2.5MG Yes No 1996/09/30 1996/09/30 LILLY Prescription
ZYPREXA 020592 002 NDA OLANZAPINE TABLET;ORAL 5MG Yes Yes 1996/09/30 1996/09/30 LILLY Prescription
ZYPREXA 020592 003 NDA OLANZAPINE TABLET;ORAL 7.5MG Yes No 1996/09/30 1996/09/30 LILLY Prescription
ZYPREXA 020592 004 NDA OLANZAPINE TABLET;ORAL 10MG Yes No 1996/09/30 1996/09/30 LILLY Prescription
ZYPREXA 020592 005 NDA OLANZAPINE TABLET;ORAL 15MG Yes No 1996/09/30 1997/09/09 LILLY Prescription
ZYPREXA 020592 006 NDA OLANZAPINE TABLET;ORAL 20MG Yes No 1996/09/30 1997/09/09 LILLY Prescription
ZYPREXA ZYDIS 021086 001 NDA OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 5MG Yes Yes 2000/04/06 2000/04/06 LILLY Prescription
ZYPREXA ZYDIS 021086 002 NDA OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 10MG Yes No 2000/04/06 2000/04/06 LILLY Prescription
ZYPREXA ZYDIS 021086 003 NDA OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 15MG Yes No 2000/04/06 2000/04/06 LILLY Prescription
ZYPREXA ZYDIS 021086 004 NDA OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 20MG Yes No 2000/04/06 2000/04/06 LILLY Prescription
ZYPREXA 021253 001 NDA OLANZAPINE INJECTABLE;INTRAMUSCULAR 10MG/VIAL Yes Yes 2004/03/29 2004/03/29 LILLY Prescription
ZYPREXA RELPREVV 022173 001 NDA OLANZAPINE PAMOATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR EQ 210MG BASE/VIAL Yes No 2009/12/11 2009/12/11 ELI LILLY CO Prescription
ZYPREXA RELPREVV 022173 002 NDA OLANZAPINE PAMOATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR EQ 300MG BASE/VIAL Yes No 2009/12/11 2009/12/11 ELI LILLY CO Prescription
ZYPREXA RELPREVV 022173 003 NDA OLANZAPINE PAMOATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR EQ 405MG BASE/VIAL Yes Yes 2009/12/11 2009/12/11 ELI LILLY CO Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database